Liuwei Dihuang pills suppress hepatocellular carcinoma via PI3K/AKT/TP53 pathway: Integrating network pharmacology, metabolomics, and experimental validation
Fields of Study & Subjects
Metabolomics and Mass Spectrometry Studies
Cancer
Hypoxia
and Metabolism
PI3K/AKT/mTOR signaling in cancer
Publication details
- Journal / source
- Phytomedicine
- Publisher
- Elsevier BV
- Volume
- 152
- Pages
- 157780–157780
- Publication date
- 6 January 2026
- Language
- EN